API Medicine Lincomycin HCl 99% Lincomycin Hydrochloride Powder CAS No. 859 -18-7

China API Medicine Lincomycin HCl 99% Lincomycin Hydrochloride Powder CAS No. 859-18-7, Find details about China Lincomycin Hydrochloride, Lincomycin HCl from API Medicine Lincomycin HCl 99% Lincomycin Hydrochloride Powder CAS No. 859-18-7

Model NO.
Lincomycin Hcl
CAS Number
859-18-7
Characters
White Crystals or Crystalline Powder
Shelf Life
3 Years
Assay
99%
Sample
Free
Coa
Available
Trademark
ORIHERB
Transport Package
Plastic Container; Aluminum Foil Bag; Fiber Drum
Origin
China
Model NO.
Lincomycin Hcl
CAS Number
859-18-7
Characters
White Crystals or Crystalline Powder
Shelf Life
3 Years
Assay
99%
Sample
Free
Coa
Available
Trademark
ORIHERB
Transport Package
Plastic Container; Aluminum Foil Bag; Fiber Drum
Origin
China

API Medicine Lincomycin HCl 99% Lincomycin Hydrochloride Powder CAS No. 859-18-7

Introduction                             

Common NameLincomycin hydrochloride
CAS Number859-18-7
WhiteWhite crystal powder
Molecular FormulaC18H35ClN2O6S
Molecular Weight442.998
Boiling Point646.8ºC at 760 mmHg
Melting Point156-158ºC

 

FUNCTION                                

 It is mainly used for the treatment of infections caused by Gram-positive bacteria in particular the various penicillin-resistant Gram-positive bacteria , the poultry chronic respiratory disease caused by Mycoplasma, swine enzootic pneumonia, anaerobic infections such as chicken necrotizing enterocolitis.

It can also be used for the treatment of treponema dysentery, toxoplasmosis and actinomycosis of dogs and cats.


APPLICATION                           

 Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. A related compound, clindamycin, is derived from lincomycin by using thionyl chlorid to replace the 7-hydroxy group with a chlorin atom with inversion of chirality. 
 
Although similar in structure, antibacterial spectrum, and mechanism of action to macrolides, lincomycin is also effective against other organisms including actinomycetes, mycoplasma, and some species of Plasmodium. Intramuscular administration of a single dose of 600 mg of Lincomycin produces average peak serum levels of 11.6 micrograms/ml at 60 minutes, and maintains therapeutic levels for 17 to 20 hours, for most susceptible gram-positive organisms. Urinary excretion after this dose ranges from 1.8 to 24.8 percent (mean: 17.3 percent). 

API Medicine Lincomycin HCl 99% Lincomycin Hydrochloride Powder CAS No. 859-18-7API Medicine Lincomycin HCl 99% Lincomycin Hydrochloride Powder CAS No. 859-18-7API Medicine Lincomycin HCl 99% Lincomycin Hydrochloride Powder CAS No. 859-18-7API Medicine Lincomycin HCl 99% Lincomycin Hydrochloride Powder CAS No. 859-18-7API Medicine Lincomycin HCl 99% Lincomycin Hydrochloride Powder CAS No. 859-18-7API Medicine Lincomycin HCl 99% Lincomycin Hydrochloride Powder CAS No. 859-18-7